Testimony of Brian Blase before the United States House Judiciary Committee Subcommittee on the Administrative State, Regulatory Reform, and Antitrust — "Examining Healthcare Markets: Fraud and Competition"
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs